Home Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends
Article
Licensed
Unlicensed Requires Authentication

Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends

  • Muhammad Waqar , Braira Wahid EMAIL logo , Muhammad Idrees , Muhammad Ali and Zobaria Rehman
Published/Copyright: June 22, 2021
Become an author with De Gruyter Brill

Abstract

The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals processed at Genome Center for Molecular Based Diagnostics and Research Pakistan, 313 (49.3%) were found SARS-CoV-2 seropositive. The study also confirmed more seroprevalence in elderly patients (>80 years) and children less than 13 years.


Corresponding author: Braira Wahid, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC, Australia, E-mail:
Muhammad Waqar and Braira Wahid have contributed equally.
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Gao, GF. From “A” IV to “Z” IKV: attacks from emerging and re-emerging pathogens. Cell 2018;172:1157–9.10.1016/j.cell.2018.02.025Search in Google Scholar

2. Candido, DS, Claro, IM, de Jesus, JG, Souza, WM, Moreira, FR, Dellicour, S, et al.. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science 2020;369:1255–60.10.1126/science.abd2161Search in Google Scholar

3. Cui, J, Li, F, Shi, Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181–92.10.1038/s41579-018-0118-9Search in Google Scholar

4. Drosten, C, Günther, S, Preiser, W, Van Der Werf, S, Brodt, HR, Becker, S, et al.. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967–76.10.1056/NEJMoa030747Search in Google Scholar

5. Fadini, G, Morieri, M, Longato, E, Avogaro, DA. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 2020;43:867–9.10.1007/s40618-020-01236-2Search in Google Scholar

6. Huang, C, Wang, Y, Li, X, Ren, L, Zhao, J, Hu, Y, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.10.1016/S0140-6736(20)30183-5Search in Google Scholar

7. Schmaljohn, C, Nichol, S. Bunyaviridae. In: Knipe, DM, Howley, PM, editors. Fields virology. Philadelphia, PA: Lippincott, Williams and Wilkins; 2007.Search in Google Scholar

8. Weiss, SR, Leibowitz, JL. Coronavirus pathogenesis Advances in virus research, Vol 81. Elsevier; 2011:85–164 pp.10.1016/B978-0-12-385885-6.00009-2Search in Google Scholar PubMed PubMed Central

9. Su, S, Wong, G, Shi, W, Liu, J, Lai, AC, Zhou, J, et al.. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490–502.10.1016/j.tim.2016.03.003Search in Google Scholar PubMed PubMed Central

10. Ksiazek, TG, Erdman, D, Goldsmith, CS, Zaki, SR, Peret, T, Emery, S, et al.. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953–66.10.1056/NEJMoa030781Search in Google Scholar PubMed

11. Zaki, AM, Van Boheemen, S, Bestebroer, TM, Osterhaus, AD, Fouchier, RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814–20.10.1056/NEJMoa1211721Search in Google Scholar PubMed

12. Zhong, N, Zheng, B, Li, Y, Poon, LL, Xie, ZH, Chan, KH, et al.. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 2003;362:1353–8.10.1016/S0140-6736(03)14630-2Search in Google Scholar

13. Zhou, P, Yang, X-L, Wang, X-G, Hu, B, Zhang, L, Zhang, W, et al.. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature 2020;579:270–3.10.1101/2020.01.22.914952Search in Google Scholar

14. Raza, H, Wahid, B, Rubi, G, Gulzar, A. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: a real-world clinical experience. Infect Genet Evol 2020;84:104374.10.1016/j.meegid.2020.104374Search in Google Scholar PubMed PubMed Central

15. Lu, J, du Plessis, L, Liu, Z, Hill, V, Kang, M, Lin, H, et al.. Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell 2020;181:997–1003.10.1016/j.cell.2020.04.023Search in Google Scholar PubMed PubMed Central

16. Hosoki, K, Chakraborty, A, Sur, S. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective. J Allergy Clin Immunol 2020;146:285–99.10.1016/j.jaci.2020.05.033Search in Google Scholar PubMed PubMed Central

17. Simonnet, A, Chetboun, M, Poissy, J, Raverdy, V, Noulette, J, Duhamel, A, et al.. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity 2020;28:1195–9.10.1002/oby.22831Search in Google Scholar PubMed PubMed Central

18. Yang, J, Zheng, Y, Gou, X, Pu, K, Chen, Z, Guo, Q, et al.. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–5.10.1016/j.ijid.2020.03.017Search in Google Scholar PubMed PubMed Central

19. Lai, C-C, Liu, YH, Wang, C-Y, Wang, YH, Hsueh, SC, Yen, MY, et al.. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. J Microbiol Immunol Infect 2020;53:404–12.10.1016/j.jmii.2020.02.012Search in Google Scholar PubMed PubMed Central

20. Machhi, J, Herskovitz, J, Senan, AM, Dutta, D, Nath, B, Oleynikov, MD, et al.. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol 2020:1–28.10.1007/s11481-020-09944-5Search in Google Scholar PubMed PubMed Central

21. He, J, Gong, L, Li, W, et al.. Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China; 2020.Search in Google Scholar

22. Lai, C-C, Shih, T-P, Ko, W-C, Tang, HJ, Hsueh, PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924.10.1016/j.ijantimicag.2020.105924Search in Google Scholar PubMed PubMed Central

23. Otto, WR, Geoghegan, S, Posch, LC, Bell, LM, Coffin, SE, Sammons, JS, et al.. The epidemiology of severe acute respiratory syndrome coronavirus 2 in a pediatric healthcare network in the United States. J Pediatr Infect Dis Soc 2020.10.1093/jpids/piaa074Search in Google Scholar

24. Ramírez, JD, Florez, C, Muñoz, M, Hernández, C, Castillo, A, Gomez, S, et al.. The arrival and spread of SARS‐CoV‐2 in Colombia. J Med Virol 2021;93:1158–63.10.1002/jmv.26393Search in Google Scholar

25. Resende, PC, Gräf, T, Paixão, ACD, Appolinario, L, Lopes, RS, Mendonça, AC, et al.. A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B. 1.1. 33 circulating in Brazil. Viruses 2021;13:724.10.3390/v13050724Search in Google Scholar

26. Faria, NR, Mellan, TA, Whittaker, C, Claro, IM, Candido, DD, Mishra, S, et al.. Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil. Science 2021.10.1126/science.abh2644Search in Google Scholar

27. Franco, D, Gonzalez, C, Abrego, LE, Carrera, JP, Diaz, Y, Caicedo, Y, et al.. Early transmission dynamics, spread, and genomic characterization of SARS-CoV-2 in Panama. Emerg Infect Dis 2021;27:612.10.3201/eid2702.203767Search in Google Scholar

28. Wise, J. Covid-19: new coronavirus variant is identified in UK. British Medical Journal Publishing Group; 2020, 371:4857 p.10.1136/bmj.m4857Search in Google Scholar

29. Anand, S, Montez-Rath, M, Han, J, Bozeman, J, Kerschmann, R, Beyer, P, et al.. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet 2020;396:1335–44.10.1016/S0140-6736(20)32009-2Search in Google Scholar

30. Zeroual, A, Harrou, F, Dairi, A, Sun, Y. Deep learning methods for forecasting COVID-19 time-series data: a comparative study. Chaos Solitons Fractals 2020:110121.10.1016/j.chaos.2020.110121Search in Google Scholar PubMed PubMed Central

Received: 2020-12-01
Accepted: 2021-05-31
Published Online: 2021-06-22
Published in Print: 2021-09-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2020-0291/html
Scroll to top button